Editorial: The role of posttranslational modifications in polyglutamine diseases

Jonasz Jeremiasz Weber; Maria do Carmo Costa; K Matthew Scaglione; Sokol V Todi; Huu Phuc Nguyen

doi:10.3389/fnmol.2023.1271226

Editorial: The role of posttranslational modifications in polyglutamine diseases

Front Mol Neurosci. 2023 Aug 15:16:1271226. doi: 10.3389/fnmol.2023.1271226. eCollection 2023.

Authors

Jonasz Jeremiasz Weber^{1

2}, Maria do Carmo Costa³, K Matthew Scaglione⁴, Sokol V Todi⁵, Huu Phuc Nguyen¹

Affiliations

¹ Department of Human Genetics, Ruhr University Bochum, Bochum, Germany.
² Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
³ Department of Neurology, Michigan Medicine, University of Michigan, Ann Arbor, MI, United States.
⁴ Department of Molecular Genetics and Microbiology, Duke University, Durham, NC, United States.
⁵ Department of Pharmacology, Wayne State University, Detroit, MI, United States.

No abstract available

Keywords: Huntington's disease; phosphorylation; protein aggregation; protein clearance; protein fragmentation; spinobulbar muscular atrophy; spinocerebellar ataxia; ubiquitination.

Publication types

Editorial

Grants and funding

JW and HN were supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG; research grant numbers NG 101/6-1 | WE 6585/1-1). MC was supported by the Heeringa ataxia research fund (University of Michigan).